IP Library › Assignment 054650/0289
Patent Assignment
Reel/Frame 054650/0289

Release of Security Interest

Recorded: 2020-12-15 Pages: 7
Assignor
KREOS CAPITAL V (UK) LIMITED
Executed: 2020-12-15
Assignee
MEREO BIOPHARMA 5, INC.
800 CHESAPEAKE DR, REDWOOD CITY, CALIFORNIA, 94063
Covered Properties (16)
Anti-Human DLL4 Antibodies and Compositions
Patent: 7,750,124 →
Application: 11/905,392 →
Publication: US 2008/0187532
Compositions and Methods for Diagnosing and Treating Cancer
Patent: 9,376,497 →
Application: 12/782,429 →
Publication: US 2010/0316637
Compositions and Methods for Diagnosing and Treating Cancer
Patent: 9,228,020 →
Application: 13/826,103 →
Publication: US 2014/0147443
Method for Making Heteromultimeric Molecules
Patent: 9,067,986 →
Application: 12/768,650 →
Publication: US 2011/0123532
Method for Making Heteromultimeric Molecules
Patent: 9,309,311 →
Application: 13/801,189 →
Publication: US 2013/0253172
Method for Making Heteromultimeric Molecules
Patent: 9,914,771 →
Application: 15/059,668 →
Publication: US 2016/0280774
Methods of Treatment with DLL4 Antagonists and an Anti-Hypertensive Agent
Patent: 8,883,145 →
Application: 13/501,944 →
Publication: US 2012/0263721
Therapeutic Combination and Methods of Treatment With A DLL4 Antagonist and an Anti-Hypertensive Agent
Patent: 9,511,139 →
Application: 14/498,602 →
Publication: US 2015/0118232
Therapeutic Combination and Methods of Treatment With A DLL4 Antagonist and an Anti-Hypertensive Agent
Patent: 9,982,042 →
Application: 15/336,272 →
Publication: US 2017/0166632
Methods for Treating Melanoma
Patent: 8,551,479 →
Application: 13/229,006 →
Publication: US 2012/0070438
Methods for Treating Melanoma
Patent: 9,480,744 →
Application: 14/020,567 →
Publication: US 2014/0065149
VEGF/DLL4 Binding Agents and Uses Thereof
Patent: 8,858,941 →
Application: 13/625,417 →
Publication: US 2013/0164295
VEGF Binding Antibodies
Patent: 9,376,488 →
Application: 14/476,582 →
Publication: US 2015/0098949
Polynucleotides Encoding VEGF/DLL4 Binding Agents
Patent: 9,574,009 →
Application: 15/163,301 →
Publication: US 2016/0362499
Modified Immunoglobulin Molecules That Specifically Bind Human VEGF and DLL4
Patent: 9,879,084 →
Application: 15/401,543 →
Publication: US 2017/0183406
Methods and Monitoring of Treatment with a DLL4 Antagonist
Patent: 9,599,620 →
Application: 14/068,910 →
Publication: US 2014/0220001
Related Assignments (20)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest May 14, 2008
From: GURNEY, AUSTIN; AXELROD, FUMIKO; HOEY, TIM; SATYAL, SANJEEV
To: ONCOMED PHARMACEUTICALS, INC.
Reel/Frame 020985/0818 →
Assignment of Assignor's Interest Jul 16, 2010
From: GURNEY, AUSTIN; AXELROD, FUMIKO; HOEY, TIM; SATYAL, SANJEEV
To: ONCOMED PHARMACEUTICALS, INC.
Reel/Frame 024698/0730 →
Assignment of Assignor's Interest Oct 18, 2010
From: GURNEY, AUSTIN L.; SATO, AARON K.
To: ONCOMED PHARMACEUTICALS, INC.
Reel/Frame 025154/0924 →
Assignment of Assignor's Interest Feb 6, 2012
From: HOEY, TIMOTHY C.; BEVIGLIA, LUCIA
To: ONCOMED PHARMACEUTICALS, INC.
Reel/Frame 027659/0138 →
Assignment of Assignor's Interest Dec 20, 2012
From: GURNEY, AUSTIN L.; SATO, AARON KEN; BOND, CHRISTOPHER JOHN
To: ONCOMED PHARMACEUTICALS, INC.
Reel/Frame 029509/0969 →
Assignment of Assignor's Interest Jan 17, 2013
From: STAGG, ROBERT JOSEPH; BENNER, STEVEN EUGENE
To: ONCOMED PHARMACEUTICALS, INC.
Reel/Frame 029647/0943 →
Assignment of Assignor's Interest Jun 7, 2013
From: GURNEY, AUSTIN; AXELROD, FUMIKO; HOEY, TIM; SATYAL, SANJEEV
To: ONCOMED PHARMACEUTICALS, INC.
Reel/Frame 030575/0944 →
Assignment of Assignor's Interest Jun 11, 2013
From: GURNEY, AUSTIN L.; SATO, AARON K.
To: ONCOMED PHARMACEUTICALS, INC.
Reel/Frame 030586/0031 →
Assignment of Assignor's Interest Nov 14, 2013
From: BENNER, STEVEN EUGENE; STAGG, ROBERT JOSEPH; DUPONT, JAKOB
To: ONCOMED PHARMACEUTICALS, INC.
Reel/Frame 031598/0550 →
Assignment of Assignor's Interest Jan 17, 2014
From: HOEY, TIMOTHY CHARLES; BEVIGLIA, LUCIA
To: ONCOMED PHARMACEUTICALS, INC.
Reel/Frame 031990/0851 →
Assignment of Assignor's Interest May 7, 2014
From: BENNER, STEVEN EUGENE; STAGG, ROBERT JOSEPH; DUPONT, JAKOB
To: ONCOMED PHARMACEUTICALS, INC.
Reel/Frame 032844/0255 →
Assignment of Assignor's Interest Dec 16, 2014
From: GURNEY, AUSTIN L.; SATO, AARON KEN; BOND, CHRISTOPHER JOHN
To: ONCOMED PHARMACEUTICALS, INC.
Reel/Frame 034517/0848 →
Assignment of Assignor's Interest Jan 14, 2015
From: STAGG, ROBERT JOSEPH; BENNER, STEVEN EUGENE
To: ONCOMED PHARMACEUTICALS, INC.
Reel/Frame 034702/0927 →
Assignment of Assignor's Interest May 24, 2016
From: GURNEY, AUSTIN L.; SATO, AARON KEN; BOND, CHRISTOPHER JOHN
To: ONCOMED PHARMACEUTICALS INC.
Reel/Frame 038706/0990 →
Assignment of Assignor's Interest Jul 1, 2016
From: GURNEY, AUSTIN L.; SATO, AARON K.
To: ONCOMED PHARMACEUTICALS, INC.
Reel/Frame 039062/0400 →
Assignment of Assignor's Interest Nov 14, 2016
From: STAGG, ROBERT JOSEPH; BENNER, STEVEN EUGENE
To: ONCOMED PHARMACEUTICALS, INC.
Reel/Frame 040310/0174 →
Assignment of Assignor's Interest Oct 23, 2017
From: GURNEY, AUSTIN L.; SATO, AARON KEN; BOND, CHRISTOPHER JOHN
To: ONCOMED PHARMACEUTICALS, INC.
Reel/Frame 043923/0940 →
Security Interest Jul 19, 2019
From: ONCOMED PHARMACEUTICALS, INC.
To: KREOS CAPITAL V (UK) LIMITED
Reel/Frame 049807/0948 →
Release of Security Interest Jan 13, 2020
From: KREOS CAPITAL V (UK) LIMITED
To: ONCOMED PHARMACEUTICALS, INC.
Reel/Frame 051574/0498 →
Change of Name Oct 5, 2020
From: ONCOMED PHARMACEUTICALS, INC.
To: MEREO BIOPHARMA 5, INC.
Reel/Frame 053981/0430 →